Meyron

Reference summary — not medical advice or a personal risk estimate.

Epstein-Barr virus (EBV)

Group 1 — carcinogenic to humansInfectionsbiologicalEvidence: sufficient_in_humans

Quick answer

Classified as Group 1 — carcinogenic to humans, based on sufficient evidence in humans. Infection. Spread through saliva; most adults are infected without symptoms. No vaccine yet.

Summary

A herpes virus that causes mononucleosis and is associated with several lymphomas and nasopharyngeal cancer.

Detail

EBV is Group 1 with sufficient evidence for nasopharyngeal cancer, Hodgkin and Burkitt lymphoma, and certain other lymphomas. >90% of people worldwide are infected; most have no symptoms. There is no vaccine yet.

What's not established

This classification is based on sufficient evidence in humans that this factor can cause cancer. It does not establish a safe exposure threshold, your personal risk, or how this factor's risk compares in size to other Group 1 agents — hazard classifications are not ranked by magnitude.

Regional relevance

global

global

Evidence sources

Every claim on this page traces back to one of these. Click through to read the primary document yourself.

Primary sources

NCI

NCI — Risk Factors: Infectious Agents

View source →

IARC

IARC Monographs — Classifications by Cancer Site, Vols 1–140

View source →

Supporting sources

ECDC

ECDC — Communicable diseases and cancer risk (European Centre for Disease Prevention and Control)

View source →

ACS

ACS — Known and Probable Human Carcinogens

View source →

Cancer Research UK

Cancer Research UK — Causes of cancer and reducing your risk

View source →

NTP

NTP — Report on Carcinogens (US National Toxicology Program)

View source →

Last reviewed: October 2026

Official reference list

A government list some readers use alongside the primary evidence. Meyron is not affiliated with it. A chemical being listed does not by itself describe a risk from any particular product.